Admedus Immunotherapies

Learn More Global Healthcare Company


Admedus Tissue Engineering

Learn More Healthcare Innovations - Baby Tissue Engineering


Admedus Medical Products

Learn More Hospital Equipment Australia

News & Media

< >

CardioCel: 8 years on and still free from calcification

CardioCel® is proving to be one of the biggest game changers in the congenital heart defect repairs and reconstructions space, offering significant long-term benefits to patients. While other tissue patches can calcify up to 18 months post implantation in paediatric patients, the latest follow up data released by Admedus shows no evidence of calcification using […]

August 23rd 2016

Find out more

Using the ADAPT engineering process to create durable tissue scaffolds

Admedus is an Australian-based healthcare company leading the world in regenerative medicine and tissue engineering research. Using its proprietary ADAPT® tissue engineering technology, Admedus can transform xenograft (animal) tissue into durable bio-scaffolds that can be used for soft tissue repair within patients. The medical technology was first brought to Australia over 20 years ago by […]

July 8th 2016

Find out more
mass device logo

Admedus shares rise on hospital infusion pump supply deal with Arcomed

Admedus said today it won a supply contract with the new Royal Adelaide Hospital for the installation of the Arcomed chroma infusion pump systems. The supply tender includes ongoing technical and clinical support as well as consumable products for the systems over the next 5 years.

May 25th 2016

Find out more

Admedus Wins 2016 Australian Manufacturer of the Year Award

After triumphing in the Most Innovative category, Admedus also took out the night’s biggest award ‘Manufacturer of the Year’. In August 2014 Admedus opened its state-of-the-art bio-manufacturing facility in Malaga, WA, and has experienced huge success in exporting its bio-scaffold regenerative medicine product, CardioCel, since then.

May 14th 2016

Find out more
The Australian Logo

Admedus HSV-2 clinical results encouraging – Morgans

Morgans healthcare analyst Scott Power talks to The Australian about Admedus’s HSV-2 Phase II clinical trial results.

March 7th 2016

Find out more

Upcoming Events


April 29th 2017 See event details

Welcome to Admedus

Admedus is a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices. Our mission is to provide patients around the world with a better quality of life through access to our leading medical solutions and products.

Learn More

CardioCel regenerative tissue scaffold

CardioCel® is a superior cardiovascular bioscaffold used to repair and reconstruct heart defects.

Read More

Our range of medical products and devices combine quality and value with the very latest technology

View our full range of products